| 存储条件 |
|---|
| Product Name | KCNQ1 [D3-E12] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ATFB1 antibody ATFB3 antibody FLJ26167 antibody IKs producing slow voltage-gated potassium channel subunit alpha antibody IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 antibody Jervell and Lange-Nielsen syndrome 1 antibody JLNS1 antibody KCNA8 antibody KCNA9 antibody KCNQ1 antibody KCNQ1_HUMAN antibody kidney and cardiac voltage dependend K+ channel antibody KQT-like 1 antibody Kv1.9 antibody Kv7.1 antibody KVLQT1 antibody long (electrocardiographic) QT syndrome, Ward-Romano syndrome 1 antibody LQT antibody LQT1 antibody Potassium channel, voltage-gated, shaker-relatd subfamily, member 9 antibody Potassium voltage-gated channel subfamily KQT member 1 antibody potassium voltage-gated channel, KQT-like subfamily, member 1 antibody RWS antibody slow delayed rectifier channel subunit antibody SQT2 antibody Voltage-gated potassium channel subunit Kv7.1 antibody WRS antibody |
| Product description | This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG2b |
| Host Species | Mouse |
| Tested Applications | WBFC |
| WB:1:500-1:2,000 FC:1:100-1:200 | |
| Species Reactivity | Human |
| Concentration | 2mg/ml |
| Alternative Names | ATFB1 antibody ATFB3 antibody FLJ26167 antibody IKs producing slow voltage-gated potassium channel subunit alpha antibody IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 antibody Jervell and Lange-Nielsen syndrome 1 antibody JLNS1 antibody KCNA8 antibody KCNA9 antibody KCNQ1 antibody KCNQ1_HUMAN antibody kidney and cardiac voltage dependend K+ channel antibody KQT-like 1 antibody Kv1.9 antibody Kv7.1 antibody KVLQT1 antibody long (electrocardiographic) QT syndrome Ward-Romano syndrome 1 antibody LQT antibody LQT1 antibody Potassium channel voltage-gated shaker-relatd subfamily member 9 antibody Potassium voltage-gated channel subfamily KQT member 1 antibody potassium voltage-gated channel KQT-like subfamily member 1 antibody RWS antibody slow delayed rectifier channel subunit antibody SQT2 antibody Voltage-gated potassium channel subunit Kv7.1 antibody WRS antibody |
|---|---|
| Molecular Weight(MW) | 75kDa (Predicted band size) |
| Cellular Localization | Membrane. Cytoplasm. |
| SwissProt ID | P51787 |
|---|
Application
Fig1: Western blot analysis of KCNQ1 on human KCNQ1 recombinant protein using anti-KCNQ1 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of KCNQ1 on CF-7 (1) and A431 (2) cell lysate using anti-KCNQ1 antibody at 1/1,000 dilution.
Application
Fig3:Flow cytometric analysis of MCF-7 cells with KCNQ1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).| Positive Control | Human KCNQ1 recombinant protein, MCF-7, A431. |
|---|---|
| Application Notes | WB:1:500-1:2,000 FC:1:100-1:200 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, Preservative: 0.05% Sodium Azide. |
抱歉，暂无相关文献
